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Abstract The interactions between the polyanionic ligands
phosphate and sulphate and the type II dehydroquinases from
Streptomyces coelicolor and Mycobacterium tuberculosis have
been characterised using a combination of structural and kinetic
methods. From both approaches, it is clear that interactions are
more complex in the case of the latter enzyme. The data provide
new insights into the di¡erences between the two enzymes in
terms of substrate recognition and catalytic e⁄ciency and
may also explain the relative potencies of rationally designed
inhibitors. An improved route to the synthesis of the substrate
3-dehydroquinic acid (dehydroquinate) is described.
& 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Dehydroquinase (3-dehydroquinate dehydratase, EC
4.2.1.10; DHQase) catalyses the reversible dehydration of
3-dehydroquinate to form 3-dehydroshikimate. This reaction
is part of two metabolic pathways: the biosynthetic shikimate
pathway and the catabolic quinate pathway [1^3]. The bio-
synthetic pathway leads in a series of seven steps to the for-
mation of chorismate, which is the precursor of a number of
aromatic compounds including the amino acids Phe, Tyr and
Trp, vitamins E and K, folate and ubiquinone. This pathway
has been considered an attractive target for the development
of antimetabolites as it is present in bacteria, higher plants,
fungi and protozoa, but absent in mammals. In the catabolic
pathway, quinate can be converted in three steps to p-hy-
droxybenzoate which can be used as a source of carbon atoms
via the L-ketoadipate pathway.
Two distinct types of enzymes have been described with
DHQase activity. Type I enzymes, which involve a syn elim-
ination reaction, usually catalyse the biosynthetic reaction. By
contrast type II enzymes, which can catalyse either the bio-
synthetic or catabolic reactions, involve an anti elimination
reaction [2,4]. The two types of DHQases are quite distinct
from one another in terms of both amino acid sequences and
three-dimensional structures [5]. Type I enzymes are dimers of
27 kDa subunits which contain an (K/L)8 fold; by contrast
type II enzymes are dodecameric with the 16 kDa subunits
arranged as tetramers of trimers. Each type II DHQase sub-
unit adopts a £avodoxin-type fold, consisting of a ¢ve-
stranded parallel L-sheet core £anked by four K-helices [5].
In terms of catalytic mechanism, type I enzymes are known
to proceed via an imine intermediate [6] whereas type II en-
zymes are believed to involve an enol [7] intermediate. High
resolution structural data are available for the type I enzyme
from Salmonella typhi and for the type II enzymes from My-
cobacterium tuberculosis and Streptomyces coelicolor [5,7].
The type II DHQases which have been kinetically charac-
terised appear to fall into two groups. The enzymes from
organisms such as S. coelicolor and Aspergillus nidulans have
high relatively values of kcat, in the range 100^1000 s31 at pH
7.0 and 25‡C [2,8]. By contrast the enzymes from Helicobacter
pylori, M. tuberculosis and Neurospora crassa have much low-
er values of kcat in the range 10 s31 or lower [3,9^11]. There
appears to be no obvious correlation between the values of
kcat and Km for these enzymes.
In this paper we characterise the interactions between type
II DHQases and the polyanionic ligands sulphate and phos-
phate using a combination of kinetic and structural ap-
proaches. Preliminary results [2] had indicated that phosphate
behaves as a competitive inhibitor of the type II DHQase
from A. nidulans, with a Ki of 10 mM at pH 7.0 and 25‡C.
In the present work we extend these studies to other type II
enzymes for both phosphate and sulphate. The X-ray crystal-
lographic data on the enzymes from S. coelicolor and
M. tuberculosis complexed with phosphate and sulphate re-
spectively, identify signi¢cant di¡erences in both the mode
of binding and number of polyanions bound by the two en-
zymes. The di¡erences in binding of the anion to the carbox-
ylate recognition site of the enzymes may account for the
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relative potencies of several rationally designed inhibitors [12].
In addition, the binding of a second anion in the position of
the lid domain of the M. tuberculosis DHQase structure may
help to explain the complex kinetic e¡ects of the polyanions
observed for this enzyme.
2. Materials and methods
2.1. Molecular biology and protein puri¢cation
The genes encoding the type II DHQases, aroD from M. tubercu-
losis and aroQ from H. pylori, have been cloned previously [9,13].
Both genes were ampli¢ed by PCR using plasmid DNA (Glaxo-
SmithKline) as a template, with the addition of a 5P NdeI restriction
site and a 3P BamHI restriction site. The PCR product was cloned into
pT7-Blue-3 (Invitrogen) by blunt-ended ligation and sequencing of
double-stranded DNA templates was undertaken by the chain termi-
nation method with ‘big dye’ terminators. The fragments were sepa-
rated and displayed on an ABI 373 DNA sequencer using ABI Prism
software. A 0.5 kb NdeI^BamHI fragment containing the gene encod-
ing DHQase was then cloned into pET-15b (Novagen), which encodes
an N-terminal 6UHis tag, and the resulting plasmids were termed
p-MPET and p-HPET respectively. p-MPET and p-HPET were trans-
formed into Escherichia coli strain BL21 DE3 (p-lysS) for over-ex-
pression.
Over-expression and puri¢cation of both 6UHis-tagged MTDH-
Qase and HPDHQase were carried out in the following manner.
E. coli cells containing the p-ET-15b-derived plasmids were grown
with shaking in 25 ml LB (Sigma) containing 100 Wg/ml ampicillin
overnight at 37‡C. These cultures were used to inoculate 500 ml of
LB+100 Wg/ml ampicillin and grown with shaking at 37‡C until the
optical density at 600 nm was between 0.4 and 0.6. Isopropyl-L-D-
thiogalactoside (0.8 mM) was added to induce expression of the plas-
mid and cells grown for 4 h. Cells were harvested by centrifugation
(4000Ug, 20 min) and resuspended in phosphate-bu¡ered saline. Cell
pellets were again centrifuged (4000Ug, 20 min) and stored at 320‡C.
Cell pellets were de-frosted and resuspended in 20 mM Tris^HCl
(Sigma), 300 mM NaCl (BDH), 20 mM imidazole (Fluka). EDTA-
free protease inhibitors (Roche), and DNase I (Sigma) were added
and cells were lysed by passage through a French press (2U950
psi). Cell debris was removed by centrifugation (8000Ug, 60 min)
and the supernatant passed through a 20 Wm ¢lter and loaded onto
a Ni-NTA super£ow column (Qiagen). All subsequent manipulations
were carried out using an FPLC system (Amersham) at 4‡C. The
column was washed with bu¡er A (20 mM Tris^HCl, 300 mM
NaCl)+20 mM imidazole until the A280 reached the baseline level.
Bu¡er A+75 mM imidazole was then used as a second wash before
elution of the 6UHis-tagged DHQase from the column with bu¡er
A+200 mM imidazole. Bu¡er exchange into bu¡er B (50 mM Tris^
HCl, 100 mM NaCl, 1 mM EDTA) was carried out using a pressure
cell concentrator (Amicon) and the protein loaded onto a Q-Sepha-
rose column (Amersham) pre-equilibrated with bu¡er B. The column
was washed with bu¡er B and the protein eluted by a salt gradient
from 100 mM to 500 mM NaCl. Puri¢ed 6UHis-tagged DHQase was
stored at 4‡C in bu¡er B, or stored at 320‡C in bu¡er B+50% glyc-
erol. SCDHQase was puri¢ed as previously reported [14].
2.2. Crystallisation and X-ray data collection
MTDHQase was concentrated to 7 mg/ml using Centricon-30 cen-
trifugal concentrators (Amicon) and crystallisation experiments car-
ried out by sitting-drop vapour di¡usion using in-house sparse matrix
screens. Crystals of size 0.1U0.1U0.1 mm were obtained in 30%
2-methylpentane-2,4-diol, 0.5 M ammonium sulphate, 0.1 M HEPES,
pH 7.5 after several weeks and required no further optimisation.
Crystals were frozen to 100 K, using arti¢cial mother liquor as cry-
oprotectant and X-ray data were collected at synchrotron radiation
source Daresbury station 9.6, using the CCD (ADSC) Quantum 4
detector. The crystals di¡racted to 1.5 AS and were found to belong
to the cubic space group F23, with unit cell dimensions
a= b= c=126.64 AS , with one monomer in the asymmetric unit.
Data were processed and scaled with DENZO and SCALEPACK
[15].
2.3. Model building and re¢nement
The structure of MTDHQase plus sulphate was solved by molecular
replacement using the stand-alone version of AMoRe [16] with the
apoMTDHQase structure (PDB I.D. 2DHQ) as a search model. A
single unambiguous peak (peak height 50% greater than the next
highest peak) was found in the rotation function. Correct translation
function solutions had correlation coe⁄cients of 54.8% and R-factors
of 39%, which were then subjected to rigid body re¢nement in
AMoRe to give a ¢nal correlation coe⁄cient of 80.3% and an R-fac-
tor of 26.3%. The structure was re¢ned using all data from 30.0 AS to
1.5 AS using REFMAC [17] from the CCP4 suite of programs [18] and
manual model building was carried out using QUANTA (Accelrys).
The ¢nal model statistics are shown in Table 1.
2.4. Synthesis of dehydroquinate
The synthesis used in this work (Scheme 1) is a modi¢cation of the
published route to (2R)-2-bromodehydroquinic acid and (2R)-2-£uo-
rodehydroquinic acid [19] and has been carried out successfully on a
gram scale. All compounds synthesised gave 1H- and 13C-NMR spec-
tra comparable with published data. Full details of the synthesis are
given in the Appendix.
Direct lactonisation of quinic acid (step a) was achieved by heating
quinic acid to re£ux in acidi¢ed benzene using a Dean-Stark appara-
tus. The secondary hydroxyl was protected (step b) by heating with
t-butyldimethylsilyl chloride (TBDMSCl) and catalytic 4-dimethyl-
aminopyridine (4-DMAP) in dimethylformamide (DMF), with the
3- and 4-monosilylated products formed in equal amounts and sepa-
rated by silica gel column chromatography. The unprotected 3-hy-
droxyl was then oxidised (step c) using pyridinium dichromate
(PDC) in the presence of 3 AS molecular sieves, and the desired prod-
uct was deprotected (step d) by treatment with acetic acid at 50‡C.
2.5. Kinetic studies of DHQase
Type II DHQase activity was assayed by monitoring the increase in
A234 accompanying conversion of 3-dehydroquinate to 3-dehydroshi-
kimate [14]. Assays were performed at 25‡C using 50 mM Tris-acetate
bu¡er, pH 7.0 in a total volume of 1 ml. Reactions were initiated by
addition of enzyme (0.015 Wg, 0.5 Wg and 3 Wg of SCDHQase,
MTDHQase and HPDHQase respectively). Kinetic parameters were
obtained by varying substrate concentrations over the appropriate
range (between 20 WM and 2 mM) in the presence and absence of
Table 1
Crystallographic and structure determination statistics
Data collection details
Data set
MTDHQ+SULPHATE
Wavelength (AS ) 0.870
Detector distance (mm) 180
Space group F23
Unit cell dimensions (a= b= c in AS ) 126.635
Resolution range (AS ) 30.0^1.45
Observations 85 115
Unique re£ections 24 274
Completeness (highest res. shell) 89.9% (32.7%a)
Rmergeb (%) 3.9
Re¢nement statistics
Resolution range (AS ) 30.0^1.5
R-factorc (Rwork/Rfree) 13.9/19.1
Number of atomsd 1058/20/200
RMS bond length deviation (AS ) 0.025
RMS bond angle deviation (‡) 1.0
Mean B-factor (AS )e 20/23/30/40
RMS backbone deviation (AS ) 1.3
Coordinate error (AS )f 0.08
aData were processed to the edge (corners) of the CCD detector
leading to a drop in completeness above 1.8 AS resolution (76% com-
plete).
bRmerge =gMI3GIfM/gGIf.
cR-factor =gMFo3FcM/gFo.
dNumber of atoms of protein, heteroatoms and water molecules re-
spectively.
eMean B-factor for main chain, side chain, inhibitor and water
atoms respectively.
fCalculated using the method of Cruickshank [24].
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sodium phosphate or sodium sulphate. The concentrations of solu-
tions of substrate were calculated on the basis of the limiting change
in A234 on addition of 1 Wg of SCDHQase, taking into account that
equilibrium constant for the reaction is 15 [20]. The values of Km and
Vmax were obtained by ¢tting the initial rate data to the Michaelis^
Menten equation by non-linear regression using Microcal Origin soft-
ware. Values of kcat were calculated using 16.5, 18.0 and 20.6 kDa for
the subunit molecular masses of SCDHQase, MTDHQase and
HPDHQase respectively. In the case of MTDHQase and HPDHQase,
the kinetic parameters of the His-tagged enzymes were very similar to
those previously reported for the corresponding native enzymes [9].
3. Results
3.1. Synthesis of dehydroquinate
The previous synthetic route to 3-dehydroquinate had in-
volved the oxidation of quinic acid by HNO3 and a lengthy
ion exchange chromatographic puri¢cation [21]. However, this
was unsatisfactory for two reasons: (i) the method leads to
formation of both 3- and 5-dehydroquinic acid [22] ; the latter
may be an inhibitor of dehydroquinase; (ii) the dehydroqui-
nate produced is an o¡-white to brown solid, even after crys-
tallisation as the ammonium salt; the consequent high back-
ground absorbance at 234 nm due to substrate makes
detection of low levels of enzyme activity extremely di⁄cult.
Direct lactonisation (Scheme 1, step a), rather than forma-
tion of the benzylidene acetal followed by hydrogenolysis
under acidic conditions according to the method of Manthey
et al. [19], was used for a number of reasons. Firstly, in our
hands heating quinic acid with benzaldehyde in acidi¢ed tolu-
ene led to charring of the reagents within 2 h; this problem
was only solved by changing to benzene as solvent. Secondly,
the hydrogenolysis step employed by Manthey et al. [19] gen-
erally led to poor yields and puri¢cation of the lactone by
crystallisation from AcOH was found to be extremely unreli-
able.
In the TBDMS protection (Scheme 1, step b), both temper-
ature and time of reaction appear to be critical. The yield of
the desired product is greatly reduced due either to incomplete
reaction if the time is too short, or to formation of the bis-
silylated compound if the reaction is left longer than 24 h. In
the oxidation step (Scheme 1, step c), the use of at least a two-
fold excess of freshly activated, powdered, 3 AS molecular
sieves is critical. If insu⁄cient sieves are present, the reaction
will not go to completion, no matter how large an excess of
PDC is used.
3.2. E¡ects of anions on the kinetic properties of DHQase
The e¡ects of phosphate and sulphate on the kinetic prop-
erties of DHQase are shown in Table 2 and Fig. 1. The poly-
anions both behave as simple competitive inhibitors with re-
spect to 3-dehydroquinate for SCDHQase and HPDHQase as
has been previously seen in the case of phosphate with respect
to the A. nidulans enzyme [2]. By contrast, in the case of
MTDHQase, the e¡ects of the anions were more complex.
Although sulphate did not change the Vmax, and thus ap-
peared to act as a competitive inhibitor (data not shown),
the dependence of the Km on the anion concentration did
not follow the expected linear model for simple competitive
inhibition. In the presence of phosphate, both Vmax and Km
were increased (Fig. 1C). These results indicate that the anions
may bind to more than one site in MTDHQase, leading to
multiple e¡ects on the kinetic properties of the enzyme.
3.3. Crystal structure of MTDHQase in complex with sulphate
The monomer fold is essentially identical to the apo-
MTDHQase structure reported previously [5], with an average
RMSD between the structures of 0.24 AS over all atoms. In the
higher resolution structure of the MTDHQase plus sulphate
the ¢rst and last residues (Leu3 and His143) are £ipped 180‡
in conformation, and electron density was present to permit
the inclusion of residues 144^146 in the structure relative to
the apoenzyme structure. The catalytically important lid do-
main is disordered as in the apoenzyme structure, with no
interpretable electron density visible between residues 19 and
26. In the sulphate complex, however, the side chain of Arg19
is visible and is positioned in the active site of the enzyme
(Fig. 2). Four sulphate molecules were identi¢ed in the struc-
ture, with two lying in the active site pocket. The ¢rst of these
(S1) is positioned in the carboxylate binding site as identi¢ed
Scheme 1. Synthesis of 3-dehydroquinate. a: 10 mol% pTsOH, PhH, re£ux (Dean-Stark), 20 h, 86%; b: 1.2 eq. TBDMSCl, 20 mol% 4-DMAP,
15 mol% Et3N, 6 mol% Bu4NI, DMF, 90‡C, 24 h, 31%; c: 2 eq. (by mass) 3 AS molecular sieves, 2.0 eq. PDC, DCM, 20‡C, 5 h, 46%;
d: H2O:AcOH 4:1, 50‡C, 48 h, 97%. Full details of the synthesis are given in the Appendix.
Table 2
Kinetic properties of type II DHQases
Enzyme Km (WM) kcat (s31) Ki (phosphate) (mM) Ki (sulphate) (mM)
SCDHQase 100 124 7 11
MTDHQase 24 5.2 a b
HPDHQase 205 0.9 9 9
Kinetic parameters were determined as indicated in Section 2. The errors in Km and kcat are less than 10% of the stated values. The errors in
the Ki values are estimated to be X 15% of the stated values.
Assays were performed in 50 mM Tris-acetate bu¡er, pH 7.0, at 25‡C.
aIn the presence of phosphate, a complex pattern is observed in which Vmax and Km are both raised (see Fig. 1).
bIn the presence of sulphate, the Vmax remains essentially unchanged, but the dependence of Km on sulphate concentration is markedly non-lin-
ear, indicating that the anion may bind to multiple sites on the enzyme.
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from the SCDHQase^inhibitor complexes [7]. The interactions
between the sulphate and Ser107 induce a small hinged move-
ment in the region of the 310 helices H2 and H3 (residues 107^
115), to bring it towards the active site. The second sulphate
(S2) interacts with the amide nitrogens of the ¢rst few residues
(17^19) of the lid domain, and with the side chain of Arg19,
changing the conformation of this region compared to the
apoenzyme. Of the sulphates not in the active site, one (S3)
lies on the crystallographic three-fold axes with occupancy
1/3, as is also seen in the SCDHQase structure. The other
sulphate (S4) interacts with the side chain of Arg50 from
strand L2 and NE1 of Trp61 and NE2 of Gln64 side chains
from helix K2.
4. Discussion
The crystal structures of SCDHQase and MTDHQase com-
plexed with phosphate and sulphate respectively were com-
pared in order to try and interpret the e¡ects of these poly-
anions on the kinetic parameters of the enzymes. From the
overlay of the CK traces of the two structures (Fig. 2) it can
be seen that the protein folds overlie well with a backbone
RMSD between the structures of 0.98 AS calculated using
LSQKAB [18]. The presence of two sulphates in the active
site of MTDHQase in comparison with the single phosphate
in SCDHQase is consistent with the more complicated kinetics
seen in the former enzyme. What is surprising is that the
single phosphate bound to SCDHQase does not correspond
to either of the sulphates bound in the active site of
MTDHQase. This ¢nding could be interpreted structurally
as the result of the di¡erences between the two ligands.
Both anions have a negative charge of two but at pH 8.5
the phosphate ion has a protonated oxygen (hydroxyl) while
sulphate does not. Therefore the protonated oxygen of the
phosphate could bind in the analogous position to the C1
hydroxyl of the substrate while this conformation would not
be as favourable for sulphate. However, the structure of the
SCDHQase^sulphate complex has been solved at 2.8 AS reso-
lution and the anion occupies exactly the same position as is
observed in the higher resolution phosphate structure [7].
A comparison of the active sites of the two DHQases is
shown in Fig. 3. If we ¢rst consider the structure of
SCDHQase (Fig. 3A), the phosphate ion forms six hydrogen
bonds; with ND1 of His106, ND2 of Asn79, OH of Tyr28,
OG of Ser108 and the amide nitrogens of Ile107 and Ser108.
The phosphate occupies a position analogous to the carboxy-
late and C1 hydroxyl of the substrate, with Tyr28 closing the
active site lid over the anion. Sequence alignments of type II
DHQases show that the H-X-S/T-N motif (residues 106^109),
where X is generally a small aliphatic residue, is strongly
conserved and essential for substrate recognition of the hy-
droxyl and carboxylate at C1. In the structure of MTDHQase
(Fig. 3B), the S1 sulphate is located in this region, but adopts
a di¡erent conformation from the P1 phosphate seen in the
S. coelicolor enzyme. Hydrogen bonds with the OG of Ser103,
the ND2 of Asn75 and backbone NH groups of the Ser103
and Ile102 are conserved. These represent the common posi-
tion of two of the oxygens of the phosphate anion. However,
His101 hydrogen bonds to a water molecule rather than the
sulphate, and the catalytically important tyrosine in the lid
domain does not close over the active site and interact with
the sulphate. Instead Arg19 has moved much further into the
Fig. 1. Inhibition of DHQase by phosphate. A: Lineweaver^Burk
plot for inhibition of SCDHQase by phosphate. Lines 1, 2, 3 and 4
refer to 0, 14, 28 and 56 mM phosphate respectively. B: Ratio of
KIm/Km vs [phosphate], where Km and K
I
m are the Michaelis con-
stants for 3-dehydroquinate in the absence and presence of phos-
phate respectively. For simple competitive inhibition, the slope of
this line= 1/Ki. C: Lineweaver^Burk plot for the e¡ect of phosphate
on MTDHQase. Lines 1, 2, 3 and 4 refer to 0, 24, 70 and 140 mM
phosphate respectively.
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active site than observed in the SCDHQase structures, and is
able to form a hydrogen bond with the sulphate. The second
sulphate ion also interacts with this arginine and also with
residues at the N-terminal end of the £exible lid domain.
Therefore, we can account for the more complicated ki-
netics seen in MTDHQase in the presence of sulphate and
phosphate. It is clear that sulphate and presumably phosphate
do not occupy exactly the same position as the C1 hydroxyl
and carboxylate of the substrate as seen in the S. coelicolor
enzyme. Therefore we would expect that inhibition would not
be as strong as that seen in the S. coelicolor enzyme. The
presence of a second sulphate interacting with residues in
part of the lid domain, in particular Arg19, a residue already
shown to be important for catalysis [8], may help to explain
the increase in Vmax seen in the presence of phosphate. This
would suggest that ordering or modi¢cation of the conforma-
tion of residues in the lid domain of MTDHQase is important
for increased catalytic activity.
The ¢nding that the sulphate anion does not occupy the
same position as the C1 hydroxyl and carboxylate of the
substrate helps to explain di¡erences in the inhibition of
type II DHQases. A number of selective inhibitors have
been synthesised by Frederickson et al. [12] including 2,3-
quinic acid and the transition state analogue 2,3-anhydro-
quinic acid. These inhibitors contain all the structural features
of the substrate and transition state respectively, with the ex-
ception of the C3 carbonyl which is absent. The Ki values for
these inhibitors were two-fold and nine-fold lower respectively
for SCDHQase than for MTDHQase. This suggests that while
recognition of the C1 carboxylate and hydroxyl is necessary
for the speci¢c binding of substrate to SCDHQase, the C3
carbonyl is more important for substrate binding by
MTDHQase, quite possibly by interacting with Arg19.
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Appendix. Supplementary information
Details of the synthetic procedure for 3-dehydroquinate are
given below. The numbers of the compounds refer to those in
Scheme 1. Standard synthetic and analytical procedures were
used throughout. Starting materials and reagents are all com-
mercially available.
Fig. 2. Stereoviews of an overlay of the Ca backbone trace of MTDHQase (black)+sulphate anions (labelled S1^S4) and SCDHQase (grey)+
phosphate anion (labelled P1). The ¢gure was produced using SETOR [23].
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(1S,3R,4R,5R)-1,4,5-Trihydroxycyclohexane-1,3-carbolac-
tone 2
Benzene (150 ml) was heated to re£ux in a Dean-Stark
apparatus for 2 h and allowed to cool to 20‡C. Quinic acid
1 (10.0 g, 52.0 mmol) and pTsOH (1.0 g, 5.8 mmol) were
added and the suspension heated to re£ux for 20 h. The ben-
zene was removed under reduced pressure and the residue
washed with EtOAc (200 ml). The EtOAc was removed by
¢ltration and the residue dried under high vacuum to give a
yellow solid (8.75 g). NMR analysis showed that the crude
material 2 (7.8 g, 44.8 mmol, 86%) could be used without
further puri¢cation. NH(400 MHz; CD3OD) 4.90 (3H, s,
3UOH), 4.74 (1H, dd, J 5.1), 4.02 (1H, t, J 4.6), 3.74 (1H,
ddd, J 11.4, 6.6 and 4.5), 2.55 (1H, d, J 11.4), 2.26 (1H, ddd, J
11.4, 6.0 and 2.9), 2.07 (1H, dddd, J 11.8, 6.6, 3.0 and 0.5),
1.91 (1H, t, J 11.6); NC(100 MHz; CD3OD) 179.87 (CO2),
78.27 (CH), 73.50 (C[OH]CO2), 67.73 (CHOH), 67.23
(CHOH), 40.50 (CH2), 38.23 (CH2); m/z (isobutane CIþ)
175.08 ([M+Hþ], 100%), 157.07 (9%), 139.07 (8%), 111.07
(11%), 79.02 (10%).
(1S,3R,4R,5R)-4-tert-Butyldimethylsiloxy-1,5-dihydroxycy-
clohexane-1,3-carbolactone 3
The lactone 2 (3.76 g, 21.6 mmol) was dissolved in dry
DMF (40 ml). TBDMSCl (3.60 g, 23.9 mmol), 4-DMAP
(0.50 g, 4.1 mmol), Et3N (3.6 ml, 25.8 mmol) and Bu4NI
(0.37 g, 1.0 mmol) were added sequentially and the solution
was heated to 90‡C under N2. After 24 h the reaction was
allowed to cool to 20‡C, diluted with EtOAc (200 ml) and
¢ltered (celite). The resulting solution was washed with 1 M
HCl (200 ml) and brine (2U200 ml), dried (MgSO4) ¢ltered
and evaporated to give the crude product (6.83 g). Silica gel
column chromatography (dichloromethane and 2^10% ace-
tone; gradient) was used for initial puri¢cation. Repeated
crystallisation (Et2O/petrol) gave the desired product 3 as
white crystals (1.81 g, 6.28 mmol, 29%). m.p. 148^152‡C (lit.
154^155‡C [19]) ; NH(400 MHz; CDCl3) 4.68 (1H, dd, J 5.7
and 5.1), 4.11 (1H, t, J 4.6), 3.82 (1H, ddt, J 11.3, 6.6, 4.5),
2.80 (1H, s), 2.53 (1H, d, J 11.5), 2.30 (1H, ddd, J 11.4, 6.1
and 3.0), 2.18 (1H, ddd, J 12.0, 6.6 and 3.0), 2.09 (1H, d, J
11.3), 1.85 (1H, t, J 11.6), 0.95 [9H, s, SiC(CH3)3], 0.17 (3H, s,
SiCH3), 0.14 (3H, s, SiCH3); NC(100 MHz; CDCl3) 178.04
(CO2), 76.88 (CH), 72.32 [C(OH)CO2], 67.14 (CH), 66.49
(CH), 41.02 (CH2), 36.77 (CH2), 26.07 [SiC(CH3)3], 18.39
(SiCMe3), 34.19 (SiCH3), 34.48 (SiCH3); m/z (isobutane
CIþ) 289.2 ([M+Hþ], 100%), 231.1 (25%), 213.1 (12%),
185.1 (20%), 169.1 (7%), 157.1 (8%), 145.1 (5%), 111.0 (5%),
85.0 (10%), 75.8 (13%).
(1S,3R,4R,5R)-4-tert-Butyldimethylsiloxy-1-hydroxy-5-oxo-
cyclohexane-1,3-carbolactone 4
3 AS molecular sieves (2.0 g) were heated under high vacuum
for 10 min and allowed to cool to 20‡C. Dry dichloromethane
(20 ml), PDC (2.5 g, 6.65 mmol) and the protected lactone 3
(0.90 g, 3.12 mmol) were added and the suspension stirred
under N2 at 20‡C. After 5 h no further change in TLC was
visible and the mixture was diluted with Et2O (150 ml) and
¢ltered (celite). The resulting solution was washed with 1 M
HCl (150 ml) and brine (2U150 ml), dried (MgSO4), ¢ltered
and evaporated to give the crude product. A £ash column
(2U6 cm silica, 400 ml Et2O) gave a white solid in a yellow
oil (0.75 g). Crystallisation (petrol) yielded the desired pro-
tected 3-dehydroquinic acid (4) as ¢ne white needle-shaped
crystals (0.41 g, 1.45 mmol, 46%) m.p. 93^94‡C, (lit. 92^
93‡C [19]); NH(400 MHz; CDCl3) 4.71 (1H, dd, J 6.2 and
3.9), 3.99 (1H, d, J 3.7), 3.23 (1H, s), 3.03 (1H, d, J 17.1),
2.79 (1H, d, J 12.2), 2.74 (1H, dd, J 17.1 and 2.4), 2.61 (1H,
ddd, J 12.1, 6.1 and 2.8), 0.89 [9H, s, SiC(CH3)3], 0.16 (3H, s,
SiCH3), 0.11 (3H, s, SiCH3); NC(100 MHz; CDCl3) 203.17
(CO), 177.51 (CO2), 75.47 (CH), 71.81 [C(OH)CO2], 71.26
(CH), 50.36 (CH2), 36.20 (CH2), 25.91 [SiC(CH3)3], 18.42
(SiCMe3), 34.49 (SiCH3), 34.85 (SiCH3); m/z (isobutane
CIþ) 287.1 ([M+Hþ], 100%), 269.1 (10%), 241.1 (8%), 229.1
(85%), 201.1 (10%), 157.1 (30%), 129.1 (7%), 75.0 (10%).
(1S,3R,4R,5R)-1,4-Hydroxy-5-oxocyclohexane-carboxylic
acid (3-dehydroquinic acid) 5
The protected compound 4 (1.73 g, 6.0 mmol) was dissolved
in water (40 ml) and acetic acid (10 ml) and heated to 50‡C.
Fig. 3. Ribbon representations of the active sites of (A) SCDHQ
with phosphate (P1) bound and (B) MTDHQase with two sulphate
ions (S1 and S2) bound. Amino acid residues important for ligand
binding are shown in stick and coloured according to atom type,
hydrogen bonds are shown as dashed lines coloured magenta. The
¢gure was produced using DINO.
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After 48 h the solution was cooled to 20‡C and the solvent
removed by freeze-drying overnight. The crude material was
dissolved in H2O (200 ml) and washed with EtOAc (2U200
ml). The water was removed by freeze-drying overnight. The
washing and freeze drying was repeated to ¢nally give 3-de-
hydroquinic acid 5 as a white solid/glass (1.04 g, 5.47 mmol,
91%). NH(400 MHz; D2O) 4.12 (1H, dd, J 9.5 and 0.6), 3.75
(1H, dt, J 9.4 and 7.1), 2.99 (1H, dd, J 14.4 and 0.7), 2.42
(1H, dt, J 14.3 and 1.6), 2.17^2.14 (2H, m); NC(100 MHz;
D2O) 208.44 (CO), 176.79 (CO2), 80.95 (CH), 74.38
(C[OH]CO2), 71.64 (CH), 47.84 (CH2), 39.86 (CH2).
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